Dr. Reddy’s plans to invest Rs 700 crore into capacity expansion of biosimilars and Active Pharmaceutical Ingredients. GV Prasad, Co-chairman and Managing Director of Dr. Reddy Laboratories shares his insights on future investments and artificial intelligence. We have seen how AI has reduced the amount of experimentation we need to do, bring more precision to our work, and give us ideas that normal human beings wouldn’t have thought about, he said while explaining how they are using machine learning to understand scaleups. For information watch this interview.
first published: Jan 15, 2024 11:02 pm
A collection of the most-viewed Moneycontrol videos.
